nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP1A2—Carmustine—melanoma	0.0911	0.229	CbGbCtD
Mirtazapine—CYP1A2—Vemurafenib—melanoma	0.072	0.181	CbGbCtD
Mirtazapine—CYP3A4—Temozolomide—melanoma	0.0688	0.173	CbGbCtD
Mirtazapine—CYP2D6—Vemurafenib—melanoma	0.0593	0.149	CbGbCtD
Mirtazapine—CYP1A2—Dacarbazine—melanoma	0.0552	0.139	CbGbCtD
Mirtazapine—CYP3A4—Vemurafenib—melanoma	0.0377	0.095	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—melanoma	0.0129	0.0326	CbGbCtD
Mirtazapine—Eye disorder—Temozolomide—melanoma	0.000533	0.00171	CcSEcCtD
Mirtazapine—Tinnitus—Temozolomide—melanoma	0.000532	0.0017	CcSEcCtD
Mirtazapine—Malaise—Bleomycin—melanoma	0.000531	0.0017	CcSEcCtD
Mirtazapine—Cardiac disorder—Temozolomide—melanoma	0.000529	0.0017	CcSEcCtD
Mirtazapine—Arrhythmia—Carmustine—melanoma	0.000527	0.00169	CcSEcCtD
Mirtazapine—Leukopenia—Bleomycin—melanoma	0.000527	0.00169	CcSEcCtD
Mirtazapine—Dizziness—Vemurafenib—melanoma	0.000524	0.00168	CcSEcCtD
Mirtazapine—Alopecia—Carmustine—melanoma	0.000521	0.00167	CcSEcCtD
Mirtazapine—Angiopathy—Temozolomide—melanoma	0.000517	0.00166	CcSEcCtD
Mirtazapine—Mental disorder—Carmustine—melanoma	0.000517	0.00166	CcSEcCtD
Mirtazapine—Ataxia—Docetaxel—melanoma	0.000515	0.00165	CcSEcCtD
Mirtazapine—Malnutrition—Carmustine—melanoma	0.000514	0.00165	CcSEcCtD
Mirtazapine—Cough—Bleomycin—melanoma	0.000514	0.00165	CcSEcCtD
Mirtazapine—Chills—Temozolomide—melanoma	0.000512	0.00164	CcSEcCtD
Mirtazapine—Dehydration—Docetaxel—melanoma	0.00051	0.00163	CcSEcCtD
Mirtazapine—Ill-defined disorder—Dactinomycin—melanoma	0.000509	0.00163	CcSEcCtD
Mirtazapine—Anaemia—Dactinomycin—melanoma	0.000507	0.00163	CcSEcCtD
Mirtazapine—Liver function test abnormal—Docetaxel—melanoma	0.000506	0.00162	CcSEcCtD
Mirtazapine—Vomiting—Vemurafenib—melanoma	0.000504	0.00162	CcSEcCtD
Mirtazapine—Alopecia—Temozolomide—melanoma	0.000504	0.00162	CcSEcCtD
Mirtazapine—Dry skin—Docetaxel—melanoma	0.000502	0.00161	CcSEcCtD
Mirtazapine—Myalgia—Bleomycin—melanoma	0.000501	0.00161	CcSEcCtD
Mirtazapine—Chest pain—Bleomycin—melanoma	0.000501	0.00161	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Docetaxel—melanoma	0.000501	0.0016	CcSEcCtD
Mirtazapine—Rash—Vemurafenib—melanoma	0.0005	0.0016	CcSEcCtD
Mirtazapine—Mental disorder—Temozolomide—melanoma	0.0005	0.0016	CcSEcCtD
Mirtazapine—Dermatitis—Vemurafenib—melanoma	0.000499	0.0016	CcSEcCtD
Mirtazapine—Back pain—Carmustine—melanoma	0.000497	0.00159	CcSEcCtD
Mirtazapine—Headache—Vemurafenib—melanoma	0.000497	0.00159	CcSEcCtD
Mirtazapine—Malnutrition—Temozolomide—melanoma	0.000496	0.00159	CcSEcCtD
Mirtazapine—Discomfort—Bleomycin—melanoma	0.000495	0.00159	CcSEcCtD
Mirtazapine—Malaise—Dactinomycin—melanoma	0.000495	0.00159	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000494	0.00158	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000494	0.00158	CcSEcCtD
Mirtazapine—Leukopenia—Dactinomycin—melanoma	0.000491	0.00157	CcSEcCtD
Mirtazapine—Dysgeusia—Temozolomide—melanoma	0.000486	0.00156	CcSEcCtD
Mirtazapine—Confusional state—Bleomycin—melanoma	0.000484	0.00155	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000484	0.00155	CcSEcCtD
Mirtazapine—Tremor—Carmustine—melanoma	0.000481	0.00154	CcSEcCtD
Mirtazapine—Oedema—Bleomycin—melanoma	0.00048	0.00154	CcSEcCtD
Mirtazapine—Back pain—Temozolomide—melanoma	0.00048	0.00154	CcSEcCtD
Mirtazapine—Infection—Bleomycin—melanoma	0.000477	0.00153	CcSEcCtD
Mirtazapine—Anaemia—Carmustine—melanoma	0.000475	0.00152	CcSEcCtD
Mirtazapine—Agitation—Carmustine—melanoma	0.000472	0.00151	CcSEcCtD
Mirtazapine—Nausea—Vemurafenib—melanoma	0.000471	0.00151	CcSEcCtD
Mirtazapine—Thrombocytopenia—Bleomycin—melanoma	0.00047	0.00151	CcSEcCtD
Mirtazapine—Myalgia—Dactinomycin—melanoma	0.000467	0.0015	CcSEcCtD
Mirtazapine—Tremor—Temozolomide—melanoma	0.000465	0.00149	CcSEcCtD
Mirtazapine—Discomfort—Dactinomycin—melanoma	0.000462	0.00148	CcSEcCtD
Mirtazapine—Angina pectoris—Docetaxel—melanoma	0.000462	0.00148	CcSEcCtD
Mirtazapine—Ill-defined disorder—Temozolomide—melanoma	0.000461	0.00148	CcSEcCtD
Mirtazapine—Leukopenia—Carmustine—melanoma	0.00046	0.00147	CcSEcCtD
Mirtazapine—Anaemia—Temozolomide—melanoma	0.000459	0.00147	CcSEcCtD
Mirtazapine—Anorexia—Bleomycin—melanoma	0.000458	0.00147	CcSEcCtD
Mirtazapine—Agitation—Temozolomide—melanoma	0.000456	0.00146	CcSEcCtD
Mirtazapine—Pancytopenia—Docetaxel—melanoma	0.00045	0.00144	CcSEcCtD
Mirtazapine—Hypotension—Bleomycin—melanoma	0.000449	0.00144	CcSEcCtD
Mirtazapine—Oedema—Dactinomycin—melanoma	0.000448	0.00144	CcSEcCtD
Mirtazapine—Malaise—Temozolomide—melanoma	0.000448	0.00143	CcSEcCtD
Mirtazapine—Vertigo—Temozolomide—melanoma	0.000446	0.00143	CcSEcCtD
Mirtazapine—Convulsion—Carmustine—melanoma	0.000445	0.00143	CcSEcCtD
Mirtazapine—Infection—Dactinomycin—melanoma	0.000445	0.00143	CcSEcCtD
Mirtazapine—Leukopenia—Temozolomide—melanoma	0.000444	0.00142	CcSEcCtD
Mirtazapine—Hypertension—Carmustine—melanoma	0.000444	0.00142	CcSEcCtD
Mirtazapine—Neutropenia—Docetaxel—melanoma	0.000443	0.00142	CcSEcCtD
Mirtazapine—Palpitations—Temozolomide—melanoma	0.000439	0.00141	CcSEcCtD
Mirtazapine—Thrombocytopenia—Dactinomycin—melanoma	0.000439	0.00141	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000438	0.0014	CcSEcCtD
Mirtazapine—Myalgia—Carmustine—melanoma	0.000437	0.0014	CcSEcCtD
Mirtazapine—Chest pain—Carmustine—melanoma	0.000437	0.0014	CcSEcCtD
Mirtazapine—Anxiety—Carmustine—melanoma	0.000436	0.0014	CcSEcCtD
Mirtazapine—Cough—Temozolomide—melanoma	0.000433	0.00139	CcSEcCtD
Mirtazapine—Paraesthesia—Bleomycin—melanoma	0.000431	0.00138	CcSEcCtD
Mirtazapine—Weight increased—Docetaxel—melanoma	0.000431	0.00138	CcSEcCtD
Mirtazapine—Convulsion—Temozolomide—melanoma	0.00043	0.00138	CcSEcCtD
Mirtazapine—Weight decreased—Docetaxel—melanoma	0.000429	0.00137	CcSEcCtD
Mirtazapine—Hypertension—Temozolomide—melanoma	0.000429	0.00137	CcSEcCtD
Mirtazapine—Dyspnoea—Bleomycin—melanoma	0.000428	0.00137	CcSEcCtD
Mirtazapine—Anorexia—Dactinomycin—melanoma	0.000427	0.00137	CcSEcCtD
Mirtazapine—Pneumonia—Docetaxel—melanoma	0.000425	0.00136	CcSEcCtD
Mirtazapine—Confusional state—Carmustine—melanoma	0.000423	0.00135	CcSEcCtD
Mirtazapine—Arthralgia—Temozolomide—melanoma	0.000423	0.00135	CcSEcCtD
Mirtazapine—Myalgia—Temozolomide—melanoma	0.000423	0.00135	CcSEcCtD
Mirtazapine—Anxiety—Temozolomide—melanoma	0.000421	0.00135	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00042	0.00135	CcSEcCtD
Mirtazapine—Oedema—Carmustine—melanoma	0.000419	0.00134	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000419	0.00134	CcSEcCtD
Mirtazapine—Discomfort—Temozolomide—melanoma	0.000418	0.00134	CcSEcCtD
Mirtazapine—Decreased appetite—Bleomycin—melanoma	0.000418	0.00134	CcSEcCtD
Mirtazapine—Infection—Carmustine—melanoma	0.000417	0.00133	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Docetaxel—melanoma	0.000416	0.00133	CcSEcCtD
Mirtazapine—Myocardial infarction—Docetaxel—melanoma	0.000414	0.00133	CcSEcCtD
Mirtazapine—Dry mouth—Temozolomide—melanoma	0.000413	0.00132	CcSEcCtD
Mirtazapine—Stomatitis—Docetaxel—melanoma	0.000412	0.00132	CcSEcCtD
Mirtazapine—Jaundice—Docetaxel—melanoma	0.000412	0.00132	CcSEcCtD
Mirtazapine—Pain—Bleomycin—melanoma	0.000411	0.00132	CcSEcCtD
Mirtazapine—Conjunctivitis—Docetaxel—melanoma	0.000411	0.00132	CcSEcCtD
Mirtazapine—Thrombocytopenia—Carmustine—melanoma	0.000411	0.00132	CcSEcCtD
Mirtazapine—Tachycardia—Carmustine—melanoma	0.000409	0.00131	CcSEcCtD
Mirtazapine—Confusional state—Temozolomide—melanoma	0.000409	0.00131	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000408	0.00131	CcSEcCtD
Mirtazapine—Oedema—Temozolomide—melanoma	0.000405	0.0013	CcSEcCtD
Mirtazapine—Infection—Temozolomide—melanoma	0.000403	0.00129	CcSEcCtD
Mirtazapine—Anorexia—Carmustine—melanoma	0.0004	0.00128	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Docetaxel—melanoma	0.0004	0.00128	CcSEcCtD
Mirtazapine—Epistaxis—Docetaxel—melanoma	0.000398	0.00128	CcSEcCtD
Mirtazapine—Nervous system disorder—Temozolomide—melanoma	0.000397	0.00127	CcSEcCtD
Mirtazapine—Thrombocytopenia—Temozolomide—melanoma	0.000397	0.00127	CcSEcCtD
Mirtazapine—Feeling abnormal—Bleomycin—melanoma	0.000396	0.00127	CcSEcCtD
Mirtazapine—Agranulocytosis—Docetaxel—melanoma	0.000394	0.00126	CcSEcCtD
Mirtazapine—Skin disorder—Temozolomide—melanoma	0.000394	0.00126	CcSEcCtD
Mirtazapine—Hypotension—Carmustine—melanoma	0.000392	0.00126	CcSEcCtD
Mirtazapine—Hyperhidrosis—Temozolomide—melanoma	0.000392	0.00126	CcSEcCtD
Mirtazapine—Decreased appetite—Dactinomycin—melanoma	0.000389	0.00125	CcSEcCtD
Mirtazapine—Fatigue—Dactinomycin—melanoma	0.000386	0.00124	CcSEcCtD
Mirtazapine—Anorexia—Temozolomide—melanoma	0.000386	0.00124	CcSEcCtD
Mirtazapine—Pain—Dactinomycin—melanoma	0.000383	0.00123	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Carmustine—melanoma	0.000382	0.00122	CcSEcCtD
Mirtazapine—Urticaria—Bleomycin—melanoma	0.000382	0.00122	CcSEcCtD
Mirtazapine—Rhinitis—Docetaxel—melanoma	0.00038	0.00122	CcSEcCtD
Mirtazapine—Body temperature increased—Bleomycin—melanoma	0.00038	0.00122	CcSEcCtD
Mirtazapine—Hepatitis—Docetaxel—melanoma	0.000379	0.00122	CcSEcCtD
Mirtazapine—Insomnia—Carmustine—melanoma	0.000379	0.00122	CcSEcCtD
Mirtazapine—Hypoaesthesia—Docetaxel—melanoma	0.000377	0.00121	CcSEcCtD
Mirtazapine—Paraesthesia—Carmustine—melanoma	0.000376	0.00121	CcSEcCtD
Mirtazapine—Pharyngitis—Docetaxel—melanoma	0.000376	0.00121	CcSEcCtD
Mirtazapine—Urinary tract disorder—Docetaxel—melanoma	0.000375	0.0012	CcSEcCtD
Mirtazapine—Dyspnoea—Carmustine—melanoma	0.000374	0.0012	CcSEcCtD
Mirtazapine—Oedema peripheral—Docetaxel—melanoma	0.000374	0.0012	CcSEcCtD
Mirtazapine—Somnolence—Carmustine—melanoma	0.000373	0.00119	CcSEcCtD
Mirtazapine—Urethral disorder—Docetaxel—melanoma	0.000372	0.00119	CcSEcCtD
Mirtazapine—Feeling abnormal—Dactinomycin—melanoma	0.000369	0.00118	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000369	0.00118	CcSEcCtD
Mirtazapine—Insomnia—Temozolomide—melanoma	0.000366	0.00117	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dactinomycin—melanoma	0.000366	0.00117	CcSEcCtD
Mirtazapine—Decreased appetite—Carmustine—melanoma	0.000364	0.00117	CcSEcCtD
Mirtazapine—Paraesthesia—Temozolomide—melanoma	0.000364	0.00117	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Carmustine—melanoma	0.000362	0.00116	CcSEcCtD
Mirtazapine—Dyspnoea—Temozolomide—melanoma	0.000361	0.00116	CcSEcCtD
Mirtazapine—Somnolence—Temozolomide—melanoma	0.00036	0.00115	CcSEcCtD
Mirtazapine—Erythema multiforme—Docetaxel—melanoma	0.000359	0.00115	CcSEcCtD
Mirtazapine—Constipation—Carmustine—melanoma	0.000359	0.00115	CcSEcCtD
Mirtazapine—Pain—Carmustine—melanoma	0.000359	0.00115	CcSEcCtD
Mirtazapine—Dyspepsia—Temozolomide—melanoma	0.000357	0.00114	CcSEcCtD
Mirtazapine—Eye disorder—Docetaxel—melanoma	0.000354	0.00114	CcSEcCtD
Mirtazapine—Body temperature increased—Dactinomycin—melanoma	0.000354	0.00113	CcSEcCtD
Mirtazapine—Abdominal pain—Dactinomycin—melanoma	0.000354	0.00113	CcSEcCtD
Mirtazapine—Hypersensitivity—Bleomycin—melanoma	0.000354	0.00113	CcSEcCtD
Mirtazapine—Decreased appetite—Temozolomide—melanoma	0.000352	0.00113	CcSEcCtD
Mirtazapine—Cardiac disorder—Docetaxel—melanoma	0.000352	0.00113	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Temozolomide—melanoma	0.00035	0.00112	CcSEcCtD
Mirtazapine—Fatigue—Temozolomide—melanoma	0.000349	0.00112	CcSEcCtD
Mirtazapine—Pain—Temozolomide—melanoma	0.000346	0.00111	CcSEcCtD
Mirtazapine—Constipation—Temozolomide—melanoma	0.000346	0.00111	CcSEcCtD
Mirtazapine—Feeling abnormal—Carmustine—melanoma	0.000346	0.00111	CcSEcCtD
Mirtazapine—Asthenia—Bleomycin—melanoma	0.000345	0.0011	CcSEcCtD
Mirtazapine—Angiopathy—Docetaxel—melanoma	0.000344	0.0011	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Carmustine—melanoma	0.000343	0.0011	CcSEcCtD
Mirtazapine—Chills—Docetaxel—melanoma	0.00034	0.00109	CcSEcCtD
Mirtazapine—Pruritus—Bleomycin—melanoma	0.00034	0.00109	CcSEcCtD
Mirtazapine—Arrhythmia—Docetaxel—melanoma	0.000339	0.00109	CcSEcCtD
Mirtazapine—Alopecia—Docetaxel—melanoma	0.000335	0.00107	CcSEcCtD
Mirtazapine—Feeling abnormal—Temozolomide—melanoma	0.000334	0.00107	CcSEcCtD
Mirtazapine—Mental disorder—Docetaxel—melanoma	0.000332	0.00106	CcSEcCtD
Mirtazapine—Abdominal pain—Carmustine—melanoma	0.000331	0.00106	CcSEcCtD
Mirtazapine—Body temperature increased—Carmustine—melanoma	0.000331	0.00106	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Temozolomide—melanoma	0.000331	0.00106	CcSEcCtD
Mirtazapine—Malnutrition—Docetaxel—melanoma	0.00033	0.00106	CcSEcCtD
Mirtazapine—Hypersensitivity—Dactinomycin—melanoma	0.00033	0.00106	CcSEcCtD
Mirtazapine—Dysgeusia—Docetaxel—melanoma	0.000323	0.00104	CcSEcCtD
Mirtazapine—Urticaria—Temozolomide—melanoma	0.000322	0.00103	CcSEcCtD
Mirtazapine—Asthenia—Dactinomycin—melanoma	0.000321	0.00103	CcSEcCtD
Mirtazapine—Abdominal pain—Temozolomide—melanoma	0.00032	0.00103	CcSEcCtD
Mirtazapine—Body temperature increased—Temozolomide—melanoma	0.00032	0.00103	CcSEcCtD
Mirtazapine—Back pain—Docetaxel—melanoma	0.000319	0.00102	CcSEcCtD
Mirtazapine—Hypersensitivity—Carmustine—melanoma	0.000309	0.00099	CcSEcCtD
Mirtazapine—Diarrhoea—Dactinomycin—melanoma	0.000307	0.000982	CcSEcCtD
Mirtazapine—Vomiting—Bleomycin—melanoma	0.000305	0.000979	CcSEcCtD
Mirtazapine—Anaemia—Docetaxel—melanoma	0.000305	0.000978	CcSEcCtD
Mirtazapine—Rash—Bleomycin—melanoma	0.000303	0.000971	CcSEcCtD
Mirtazapine—Dermatitis—Bleomycin—melanoma	0.000303	0.00097	CcSEcCtD
Mirtazapine—Asthenia—Carmustine—melanoma	0.000301	0.000964	CcSEcCtD
Mirtazapine—Hypersensitivity—Temozolomide—melanoma	0.000299	0.000957	CcSEcCtD
Mirtazapine—Syncope—Docetaxel—melanoma	0.000296	0.000949	CcSEcCtD
Mirtazapine—Leukopenia—Docetaxel—melanoma	0.000296	0.000947	CcSEcCtD
Mirtazapine—Palpitations—Docetaxel—melanoma	0.000292	0.000935	CcSEcCtD
Mirtazapine—Asthenia—Temozolomide—melanoma	0.000291	0.000932	CcSEcCtD
Mirtazapine—Loss of consciousness—Docetaxel—melanoma	0.00029	0.00093	CcSEcCtD
Mirtazapine—Cough—Docetaxel—melanoma	0.000288	0.000923	CcSEcCtD
Mirtazapine—Diarrhoea—Carmustine—melanoma	0.000287	0.000919	CcSEcCtD
Mirtazapine—Pruritus—Temozolomide—melanoma	0.000287	0.000919	CcSEcCtD
Mirtazapine—Convulsion—Docetaxel—melanoma	0.000286	0.000917	CcSEcCtD
Mirtazapine—Nausea—Bleomycin—melanoma	0.000285	0.000914	CcSEcCtD
Mirtazapine—Hypertension—Docetaxel—melanoma	0.000285	0.000914	CcSEcCtD
Mirtazapine—Vomiting—Dactinomycin—melanoma	0.000285	0.000913	CcSEcCtD
Mirtazapine—Rash—Dactinomycin—melanoma	0.000282	0.000905	CcSEcCtD
Mirtazapine—Chest pain—Docetaxel—melanoma	0.000281	0.000901	CcSEcCtD
Mirtazapine—Myalgia—Docetaxel—melanoma	0.000281	0.000901	CcSEcCtD
Mirtazapine—Arthralgia—Docetaxel—melanoma	0.000281	0.000901	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000279	0.000895	CcSEcCtD
Mirtazapine—Dizziness—Carmustine—melanoma	0.000277	0.000889	CcSEcCtD
Mirtazapine—Diarrhoea—Temozolomide—melanoma	0.000277	0.000888	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—melanoma	0.000275	0.000881	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—melanoma	0.000272	0.000871	CcSEcCtD
Mirtazapine—Oedema—Docetaxel—melanoma	0.000269	0.000864	CcSEcCtD
Mirtazapine—Dizziness—Temozolomide—melanoma	0.000268	0.000859	CcSEcCtD
Mirtazapine—Infection—Docetaxel—melanoma	0.000268	0.000858	CcSEcCtD
Mirtazapine—Vomiting—Carmustine—melanoma	0.000267	0.000854	CcSEcCtD
Mirtazapine—Nausea—Dactinomycin—melanoma	0.000266	0.000853	CcSEcCtD
Mirtazapine—Shock—Docetaxel—melanoma	0.000265	0.00085	CcSEcCtD
Mirtazapine—Rash—Carmustine—melanoma	0.000264	0.000847	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—melanoma	0.000264	0.000847	CcSEcCtD
Mirtazapine—Dermatitis—Carmustine—melanoma	0.000264	0.000846	CcSEcCtD
Mirtazapine—Thrombocytopenia—Docetaxel—melanoma	0.000264	0.000845	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—melanoma	0.000263	0.000843	CcSEcCtD
Mirtazapine—Headache—Carmustine—melanoma	0.000263	0.000842	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—melanoma	0.000262	0.000839	CcSEcCtD
Mirtazapine—Vomiting—Temozolomide—melanoma	0.000258	0.000826	CcSEcCtD
Mirtazapine—Anorexia—Docetaxel—melanoma	0.000257	0.000823	CcSEcCtD
Mirtazapine—Rash—Temozolomide—melanoma	0.000255	0.000819	CcSEcCtD
Mirtazapine—Dermatitis—Temozolomide—melanoma	0.000255	0.000818	CcSEcCtD
Mirtazapine—Headache—Temozolomide—melanoma	0.000254	0.000813	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—melanoma	0.000252	0.000807	CcSEcCtD
Mirtazapine—Nausea—Carmustine—melanoma	0.000249	0.000798	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000245	0.000787	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—melanoma	0.000244	0.000781	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—melanoma	0.000242	0.000775	CcSEcCtD
Mirtazapine—Nausea—Temozolomide—melanoma	0.000241	0.000771	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—melanoma	0.00024	0.00077	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—melanoma	0.00024	0.000768	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—melanoma	0.000237	0.00076	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—melanoma	0.000234	0.000751	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—melanoma	0.000233	0.000746	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—melanoma	0.000232	0.000744	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—melanoma	0.00023	0.000738	CcSEcCtD
Mirtazapine—Pain—Docetaxel—melanoma	0.00023	0.000738	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—melanoma	0.000222	0.000712	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—melanoma	0.00022	0.000706	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—melanoma	0.000213	0.000683	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—melanoma	0.000213	0.000683	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—melanoma	0.000199	0.000636	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—melanoma	0.000193	0.00062	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—melanoma	0.000191	0.000611	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—melanoma	0.000184	0.000591	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—melanoma	0.000178	0.000571	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—melanoma	0.000171	0.000549	CcSEcCtD
Mirtazapine—Rash—Docetaxel—melanoma	0.00017	0.000544	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—melanoma	0.00017	0.000544	CcSEcCtD
Mirtazapine—Headache—Docetaxel—melanoma	0.000169	0.000541	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—melanoma	0.00016	0.000513	CcSEcCtD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—melanoma	5.6e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	5.59e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—melanoma	5.59e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—melanoma	5.59e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—melanoma	5.58e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—melanoma	5.58e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—melanoma	5.57e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—melanoma	5.56e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—melanoma	5.55e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—melanoma	5.55e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—melanoma	5.55e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—melanoma	5.54e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	5.54e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	5.53e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—melanoma	5.5e-06	1.89e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—melanoma	5.48e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—melanoma	5.48e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—melanoma	5.47e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—melanoma	5.47e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—melanoma	5.45e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—melanoma	5.45e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—melanoma	5.45e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—melanoma	5.44e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—melanoma	5.44e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—melanoma	5.44e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—melanoma	5.43e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—melanoma	5.43e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—melanoma	5.42e-06	1.86e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—melanoma	5.4e-06	1.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—melanoma	5.4e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—melanoma	5.39e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—melanoma	5.38e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—melanoma	5.38e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—melanoma	5.37e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—melanoma	5.36e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—melanoma	5.36e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—melanoma	5.36e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—melanoma	5.34e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—melanoma	5.33e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—melanoma	5.32e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—melanoma	5.32e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—melanoma	5.32e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NFKB1—melanoma	5.32e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—melanoma	5.3e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—melanoma	5.29e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—melanoma	5.29e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—melanoma	5.29e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	5.28e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—melanoma	5.28e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—melanoma	5.27e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—melanoma	5.27e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—melanoma	5.26e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—melanoma	5.26e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—melanoma	5.26e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—melanoma	5.26e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—melanoma	5.25e-06	1.8e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NFKB1—melanoma	5.23e-06	1.8e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NFKB1—melanoma	5.22e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—melanoma	5.21e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—melanoma	5.21e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—melanoma	5.21e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—melanoma	5.2e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	5.2e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—melanoma	5.18e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—melanoma	5.17e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—melanoma	5.17e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—melanoma	5.17e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—melanoma	5.17e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	5.16e-06	1.77e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—melanoma	5.15e-06	1.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	5.14e-06	1.77e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—melanoma	5.13e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—melanoma	5.13e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—melanoma	5.13e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NFKB1—melanoma	5.12e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—melanoma	5.12e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—melanoma	5.12e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—melanoma	5.11e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—melanoma	5.09e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—melanoma	5.08e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—melanoma	5.06e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—melanoma	5.06e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—melanoma	5.06e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—melanoma	5.06e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—melanoma	5.03e-06	1.73e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—melanoma	5.03e-06	1.73e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—melanoma	5.02e-06	1.73e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5e-06	1.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—melanoma	4.97e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—melanoma	4.96e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—melanoma	4.95e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—melanoma	4.95e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—melanoma	4.95e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—melanoma	4.93e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—melanoma	4.92e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—melanoma	4.92e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—melanoma	4.91e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	4.91e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—melanoma	4.91e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—melanoma	4.9e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—melanoma	4.9e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—melanoma	4.89e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—melanoma	4.89e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—melanoma	4.84e-06	1.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—melanoma	4.83e-06	1.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—melanoma	4.81e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—melanoma	4.81e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	4.8e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—melanoma	4.79e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—melanoma	4.79e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—melanoma	4.78e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—melanoma	4.78e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—melanoma	4.78e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—melanoma	4.77e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—melanoma	4.77e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—melanoma	4.77e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NFKB1—melanoma	4.76e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—melanoma	4.75e-06	1.63e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—melanoma	4.74e-06	1.63e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—melanoma	4.73e-06	1.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—melanoma	4.7e-06	1.62e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PRKCA—melanoma	4.7e-06	1.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—melanoma	4.69e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—melanoma	4.69e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—melanoma	4.69e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—melanoma	4.68e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—melanoma	4.67e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—melanoma	4.67e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—melanoma	4.66e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—melanoma	4.65e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—melanoma	4.65e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—melanoma	4.61e-06	1.58e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—melanoma	4.6e-06	1.58e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—melanoma	4.59e-06	1.58e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—melanoma	4.57e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—melanoma	4.56e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—melanoma	4.54e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—melanoma	4.53e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—melanoma	4.52e-06	1.55e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—melanoma	4.49e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—melanoma	4.49e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—melanoma	4.48e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—melanoma	4.44e-06	1.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—melanoma	4.4e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—melanoma	4.39e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—melanoma	4.37e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—melanoma	4.36e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—melanoma	4.36e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—melanoma	4.35e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—melanoma	4.34e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—melanoma	4.34e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—melanoma	4.33e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—melanoma	4.32e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—melanoma	4.31e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—melanoma	4.29e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—melanoma	4.28e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—melanoma	4.28e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—melanoma	4.28e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—melanoma	4.28e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—melanoma	4.28e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—melanoma	4.27e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—melanoma	4.27e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—melanoma	4.27e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—melanoma	4.27e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—melanoma	4.27e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—melanoma	4.25e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—melanoma	4.24e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—melanoma	4.19e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—melanoma	4.19e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—melanoma	4.19e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	4.16e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—melanoma	4.15e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—melanoma	4.15e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—melanoma	4.14e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—melanoma	4.13e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—melanoma	4.1e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—melanoma	4.09e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—melanoma	4.06e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—melanoma	4.06e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—melanoma	4.04e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—melanoma	4.04e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—melanoma	4.03e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—melanoma	4.03e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—melanoma	4.02e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—melanoma	3.98e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—melanoma	3.98e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—melanoma	3.97e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—melanoma	3.95e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—melanoma	3.95e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—melanoma	3.89e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—melanoma	3.89e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—melanoma	3.89e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—melanoma	3.84e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—melanoma	3.8e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—melanoma	3.78e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—melanoma	3.77e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—melanoma	3.73e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—melanoma	3.71e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—melanoma	3.7e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—melanoma	3.7e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—melanoma	3.68e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—melanoma	3.68e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—melanoma	3.67e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—melanoma	3.67e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—melanoma	3.66e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—melanoma	3.65e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	3.63e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—melanoma	3.62e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—melanoma	3.59e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—melanoma	3.59e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—melanoma	3.58e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—melanoma	3.55e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—melanoma	3.51e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—melanoma	3.51e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—melanoma	3.49e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—melanoma	3.49e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—melanoma	3.43e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—melanoma	3.42e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—melanoma	3.39e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	3.38e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—melanoma	3.36e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—melanoma	3.34e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—melanoma	3.3e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—melanoma	3.29e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—melanoma	3.28e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—melanoma	3.27e-06	1.12e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—melanoma	3.24e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—melanoma	3.22e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—melanoma	3.2e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—melanoma	3.19e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—melanoma	3.16e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—melanoma	3.12e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—melanoma	3.08e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—melanoma	3.03e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—melanoma	3.02e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—melanoma	2.99e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—melanoma	2.97e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—melanoma	2.82e-06	9.7e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—melanoma	2.8e-06	9.61e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—melanoma	2.76e-06	9.48e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—melanoma	2.63e-06	9.04e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—melanoma	2.62e-06	9e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—melanoma	2.61e-06	8.96e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—melanoma	2.44e-06	8.38e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—melanoma	2.23e-06	7.66e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—melanoma	2.15e-06	7.38e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—melanoma	2.13e-06	7.32e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—melanoma	1.82e-06	6.26e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—melanoma	1.72e-06	5.91e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—melanoma	1.4e-06	4.83e-06	CbGpPWpGaD
